Global Medical REIT Inc. (XRN)

Global Medical REIT Statistics

Total Valuation

XRN has a market cap or net worth of $504.19 million. The enterprise value is $1.21 billion.

Market Cap	504.19M
Enterprise Value	1.21B

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	Dec 19, 2025

Share Statistics

XRN has 13.85 million shares outstanding. The number of shares has increased by 1.95% in one year.

Current Share Class	13.41M
Shares Outstanding	13.85M
Shares Change (YoY)	+1.95%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	0.55%
Owned by Institutions (%)	65.54%
Float	12.59M

Valuation Ratios

Price/FFO Ratio	n/a
Price/AFFO Ratio	n/a
PE Ratio	n/a
Forward PE	166.86
PS Ratio	3.46
Forward PS	n/a
PB Ratio	1.17
P/TBV Ratio	1.36
P/FCF Ratio	n/a
P/OCF Ratio	6.92
PEG Ratio	23.31

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.36
EV / EBITDA	13.83
EV / EBIT	35.44
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 1.43.

Current Ratio	1.91
Quick Ratio	1.71
Debt / Equity	1.43
Debt / EBITDA	7.84
Debt / FCF	n/a
Interest Coverage	1.10

Financial Efficiency

Return on equity (ROE) is 0.41% and return on invested capital (ROIC) is 1.76%.

Return on Equity (ROE)	0.41%
Return on Assets (ROA)	1.70%
Return on Invested Capital (ROIC)	1.76%
Return on Capital Employed (ROCE)	2.75%
Weighted Average Cost of Capital (WACC)	6.45%
Revenue Per Employee	$5.57M
Profits Per Employee	-$127,846
Employee Count	26
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.33% in the last 52 weeks. The beta is 1.20, so XRN's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	-12.33%
50-Day Moving Average	35.20
200-Day Moving Average	34.04
Relative Strength Index (RSI)	60.75
Average Volume (20 Days)	80,555

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XRN had revenue of $144.83 million and -$3.32 million in losses. Loss per share was -$0.25.

Revenue	144.83M
Gross Profit	144.67M
Operating Income	34.15M
Pretax Income	2.20M
Net Income	-3.32M
EBITDA	87.53M
EBIT	34.15M
Loss Per Share	-$0.25

Balance Sheet

The company has $14.59 million in cash and $723.14 million in debt, with a net cash position of -$708.55 million or -$51.15 per share.

Cash & Cash Equivalents	14.59M
Total Debt	723.14M
Net Cash	-708.55M
Net Cash Per Share	-$51.15
Equity (Book Value)	505.83M
Book Value Per Share	30.61
Working Capital	27.32M

Cash Flow

Operating Cash Flow	72.50M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 99.89%, with operating and profit margins of 23.58% and 1.72%.

Gross Margin	99.89%
Operating Margin	23.58%
Pretax Margin	1.52%
Profit Margin	1.72%
EBITDA Margin	60.44%
EBIT Margin	23.58%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of $3.00, which amounts to a dividend yield of 8.17%.

Dividend Per Share	$3.00
Dividend Yield	8.17%
Dividend Growth (YoY)	-21.43%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.95%
Shareholder Yield	6.33%
Earnings Yield	-0.66%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 22, 2025. It was a reverse split with a ratio of 1:5.

Last Split Date	Sep 22, 2025
Split Type	Reverse
Split Ratio	1:5

Scores

Altman Z-Score	n/a
Piotroski F-Score	4